Depression (Episode 2 of 4) — Treatment Options and Managing Depression in Primary Care | NEJM
In this second episode of a four-part Double Take video miniseries on depression
from the New England Journal of Medicine, Drs. Anderson, Teel, and Scott-Vernaglia
discuss available treatments for depression, including psychotherapy and first-line
and second-line antidepressants. Dr. Sanacora and the other physicians
advise on how to monitor a patient undergoing therapy as well as how and
when to consider augmenting a medication or switching a patient to a different
medication.
The _New England Journal of Medicine_ is the world’s leading general medical
journal. Continuously published for over 200 years, the _Journal_ publishes
peer-reviewed research along with interactive clinical content for physicians,
educators, and the global medical community at https://NEJM.org.
#depression #depressionmanagement #mentalhealth #mentalillness #nejm
3 Comments
I wanna try energy healing is it good
Spring 2022 you guys came out with clinical trials about obesity weight loss.was very promising..I would like to know what happened with all that?.I called your clinic back east…most of all these studies and giving people hope ends rite there.been waiting and checking for farther drugs on obesity 2 yrs later.
Please remember to rule out bipolar depression before starting any medication for unipolar depression (MDD)
Rexulti, Vraylar, Abilify, and Seroquel are also FDA approved as adjunctive treatments for MDD in combination with any antidepressant. Primary care doctors should be able to competently prescribe those, especially the newer ones that have less metabolic side effects. It’s a shame they are not mentioned because they are much easier to prescribe and manage than MAOIs, which are mentioned